Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Hypertension, Portal

1-methyl-3-isobutylxanthine has been researched along with Hypertension, Portal in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research Excerpts

ExcerptRelevanceReference
"Portal hypertension was induced by partial portal vein ligation (PVL) in Sprague-Dawley rats."1.29Change in vascular cAMP and cGMP contents in portal hypertensive rats. ( Hong, CY; Huang, YT; Lin, HC; Lo, JW; Tsai, YT; Yang, MC, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, YT1
Lo, JW1
Lin, HC1
Tsai, YT1
Hong, CY1
Yang, MC1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Hypertension, Portal

ArticleYear
Change in vascular cAMP and cGMP contents in portal hypertensive rats.
    Pharmacology, 1995, Volume: 50, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Arteries; Colforsin; Cyclic AMP; Cyclic GMP; Hemodynamics; Hyp

1995